Thomas Trimarchi Bridge Bio Pharma, Inc. (BBIO) insider trading activity

Thomas Trimarchi is President and CFO of BridgeBio Pharma, Inc.. Currently has a direct ownership of 369,004 shares of BBIO, which is worth approximately $24.5 Million. The most recent transaction as insider was on Dec 12, 2025, when has been sold 13,826 shares (Common Stock) at a price of $75.15 per share, resulting in proceeds of $1,039,023. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 369K

12.37% 3M change

13.78% 12M change

Total Value Held $24.5 Million

Thomas Trimarchi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 12 2025	SELL Payment of exercise price or tax liability	$1,039,023 $75.15 p/Share	13,826 Reduced 3.61%	369,004 Common Stock
Nov 17 2025	SELL Open market or private sale	$1,126,280 $66.51 p/Share	16,934 Reduced 4.24%	382,830 Common Stock
Nov 16 2025	SELL Payment of exercise price or tax liability	$1,415,235 $66.39 p/Share	21,317 Reduced 5.06%	399,764 Common Stock
Aug 21 2025	SELL Open market or private sale	$2,089,886 $49.48 p/Share	42,237 Reduced 9.12%	421,081 Common Stock
Aug 18 2025	SELL Open market or private sale	$877,020 $50.54 p/Share	17,353 Reduced 3.61%	463,318 Common Stock
Aug 16 2025	SELL Payment of exercise price or tax liability	$1,093,988 $51.32 p/Share	21,317 Reduced 4.25%	480,671 Common Stock
May 16 2025	SELL Payment of exercise price or tax liability	$721,367 $33.84 p/Share	21,317 Reduced 4.07%	501,988 Common Stock

Mar 19 2025	BUY Grant, award, or other acquisition	-	109,100 Added 17.25%	523,305 Common Stock
Feb 16 2025	SELL Payment of exercise price or tax liability	$480,991 $34.9 p/Share	13,782 Reduced 3.22%	414,205 Common Stock
Dec 10 2024	BUY Grant, award, or other acquisition	-	50,000 Added 10.46%	427,987 Common Stock
Nov 16 2024	SELL Payment of exercise price or tax liability	$425,441 $23.72 p/Share	17,936 Reduced 4.53%	377,987 Common Stock
Aug 16 2024	SELL Payment of exercise price or tax liability	$437,638 $24.4 p/Share	17,936 Reduced 4.33%	395,923 Common Stock
Aug 06 2024	BUY Grant, award, or other acquisition	-	19,003 Added 4.39%	413,859 Common Stock

Thomas Trimarchi

President and CFO

Palo Alto, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Value

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to BridgeBio Pharma, Inc.

Track Activities on BBIO

Account